TELEHEALTH · PATIENT ACQUISITION

Growth marketing for telehealth brands

Paid acquisition built for telehealth economics - LTV:CAC and payback by sub-vertical, with the creative volume it actually takes to hold your benchmark.

Typical CAC $150–$500 Compliance-first Setup in 5 days
The short answer Built a telehealth acquisition engine from a cold start to $1.6M in 90 days. We only work in health, so the playbook, creative, and compliance are purpose-built for telehealth - not adapted from a generic DTC template.

Market context

The US telehealth market reached ~$52.8B in 2025 and is projected at ~$65.4B in 2026, with DTC subscription telehealth growing fastest at ~30% CAGR toward $9.5B by 2030. The urgent 2026 dynamic: on Dec 31, 2025 the DEA/HHS issued a fourth extension keeping telemedicine controlled-substance prescribing legal without a prior in-person visit through Dec 31, 2026 - but the permanent rule is unfinalized, so operators are marketing into a one-year regulatory window that could tighten overnight.

The telehealth growth playbook

Most telehealth brands quote consult CAC as if it were paying-patient CAC - and starve their ad account of the 30–60 fresh creatives a month it takes to stay efficient.

Google captures demand, Meta creates it, TikTok fuels the top

Google Search wins on high-intent, condition-specific queries where buyers are ready. Meta remains the volume workhorse for stigma-sensitive conditions, but its Nov 2025 health restrictions block Purchase/Lead optimization for many telehealth advertisers (30–40% efficiency drops reported) - shift to upper-funnel events and rebuild signal with server-side/CAPI. Add TikTok as a lower-CPM top-funnel channel for de-stigmatized categories.

Creative: convenience, privacy, speed-to-Rx

The three hooks that outperform: convenience ("skip the waiting room"), stigma-free discretion (ED, mental health, hair loss - "discreet packaging"), and speed ("online visit to prescription in 24 hours"). Founder/patient UGC beats polished brand spots. Lead with the outcome and the ease - avoid disease/symptom claims that trip platform policy.

Symptom quiz → condition-specific LP → membership

A short symptom/eligibility quiz feeds a dedicated condition page, not a generic homepage (wellness LPs median ~8.2% conversion vs ~5.1% general healthcare). Use a low-friction first-visit offer ($0–$20) to clear the async hurdle, then convert to an auto-refill membership. Price the subscription, not the visit - the visit is a loss-leader to acquire a recurring Rx relationship.

LTV: refill cadence + condition stacking

Episodic care becomes subscription revenue - Hims grew online revenue per subscriber to ~$73/mo in 2024 (+38% YoY) largely via cross-sell. Lock in 30/90-day auto-refill, stack conditions (finasteride + minoxidil, or ED + GLP-1) to raise ARPU without new CAC, and cross-sell across the lifecycle. This is what justifies $700–$930 CACs at scaled players.

Compliance landmines

Watch for thisPrescription and “Rx” language, personal-health targeting, and HIPAA-adjacent claims. Google requires LegitScript certification for telehealth/pharmacy advertisers. Telehealth CAC benchmarks: what top brands pay per patient →

Common mistakes in telehealth

  • Launching paid before securing LegitScript certification - Google, Meta, Bing and TikTok reject telehealth/pharmacy ads without it.
  • Running generic "see a doctor online" messaging instead of condition-specific angles - it buries intent and forfeits the 8%+ conversion dedicated LPs deliver.
  • Pointing high-intent traffic at a homepage instead of a condition-specific landing page with a matching quiz.
  • Still optimizing Meta for Purchase/Lead events after the Nov 2025 health-tier restrictions blocked them, inflating CPAs 30–40%.
  • Nailing the async quiz but losing patients at the async-to-sync handoff (ID verification, provider review, pharmacy fulfillment).

What good looks like

  • Blended CAC $150–$400 early/niche; $700–$930 scaled multi-category
  • Quiz-to-paid-subscription conversion 10–20%
  • Monthly churn 5–8% (target sub-5% for refill categories)
  • Condition-specific LP conversion 8–12% vs ~2.3% generic ecommerce

Segments we work in

Men’s sexual health & hair lossMental health & psychiatryWeight management / GLP-1Dermatology / skincareSexual health & STI / women’s health

What we do for telehealth brands

Compliant paid media

Meta, Google & TikTok, structured for this vertical’s auction.

Learn more →

In-house creative

20+ compliant variants a month, built around winning angles.

Learn more →

CRO & funnels

Quiz funnels and landers tuned to LTV and payback.

Learn more →

Telehealth marketing FAQ

It depends heavily on sub-vertical: ED runs $70–$140, hair loss $90–$170, GLP-1 $180–$400, and mental health $200–$400. Across the board, aim for an LTV:CAC of at least 3:1 and payback under 12 months.

For Google Ads, telehealth and online-pharmacy advertisers generally need LegitScript certification before running. Meta also restricts prescription-related advertising. Certification and a compliance review before launch prevent the account disruptions that wreck telehealth CAC.

For now, yes. The DEA/HHS fourth extension (through Dec 31, 2026) preserves flexibility to prescribe Schedule II–V without a prior in-person visit. But the permanent Special Registration rule is unfinalized and could impose in-person requirements after 2026 - don’t build a growth model that assumes these flexibilities are permanent.

You can only treat patients in states where you have a licensed provider, and controlled-substance prescribing must comply with each state’s law on top of federal rules. Geo-gate paid campaigns and landing-page eligibility to your covered states, and add states to your provider network before scaling spend into them.

Ready to lower CAC on your telehealth brand?

A 30-minute call with a senior strategist. Free account audit included. No pitch deck - a written plan you can keep, whether you work with us or not.

Book a free strategy call
30 minutes Free account audit Written plan either way
Book a free strategy call